Aquestive Therapeutics Inc

NASDAQ:AQST   3:43:28 PM EDT
3.40
+0.11 (+3.34%)
Other Pre-Announcement

Aquestive Sees 2021 Total Revenue Of About $38 Million To $42 Million

Published: 03/10/2021 00:00 GMT
Aquestive Therapeutics Inc (AQST) - Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update.
Q4 Revenue $7.1 Million Versus Refinitiv Ibes Estimate of $6.2 Million.
Net Loss for Q4 2020 Was $20.4 Million, Or $0.60 Loss per Share.
Sees 2021 Total Revenues of Approximately $38 Million to $42 Million.
Sees 2021 Non-GAAP Adjusted EBITDA Loss of Approximately $42 Million to $45 Million.